Does threshold growth benefit imaging criteria when used as a major diagnostic imaging feature for hepatocellular carcinoma?

Comparison of gadoxetate disodium-enhanced MRI sequences for measuring hepatic observation size and its implication of LI-RADS classification

(2022) Ji Young Choi et al.   Abdominal Radiology

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

(2022)   Clinical and Molecular Hepatology

Value of threshold growth as a major diagnostic feature of hepatocellular carcinoma in LI-RADS

(2022) Se Jin Choi et al.   JOURNAL OF HEPATOLOGY

Comparison of LI-RADS with other non-invasive liver MRI criteria and radiological opinion for diagnosing hepatocellular carcinoma in cirrhotic livers using gadoxetic acid with histopathological explant correlation

(2021) C.G.D. Clarke et al.   CLINICAL RADIOLOGY

Comparison of the current guidelines for diagnosing hepatocellular carcinoma using gadoxetic acid–enhanced magnetic resonance imaging

(2021) Shin Hye Hwang et al.   EUROPEAN RADIOLOGY

Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid–enhanced MRI in at-risk patients

(2021) So Hyun Park et al.   EUROPEAN RADIOLOGY

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Imaging Diagnosis of HCC: Future directions with special emphasis on hepatobiliary MRI and contrast-enhanced ultrasound

(2021) Junghoan Park et al.   Clinical and Molecular Hepatology

Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid–enhanced MRI in transplantation candidates

(2020) Sun Kyung Jeon et al.   EUROPEAN RADIOLOGY

Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI

(2020) Jieun Byun et al.   Hepatology International

Is It Time to Expand the Definition of Washout Appearance in LI-RADS?

(2019) Kathryn J. Fowler et al.   RADIOLOGY

Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging

(2019) Christoph J. Zech et al.   EUROPEAN RADIOLOGY

A global view of hepatocellular carcinoma: trends, risk, prevention and management

(2019) Ju Dong Yang et al.   Nature Reviews Gastroenterology & Hepatology

Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

(2018) Jorge A. Marrero et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2018) Peter R. Galle et al.   JOURNAL OF HEPATOLOGY

Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014

(2018) Tyler J. Fraum et al.   RADIOLOGY

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

(2017) Masao Omata et al.   Hepatology International

Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging

(2016) Sang Hyun Choi et al.   JOURNAL OF HEPATOLOGY

The Diagnostic Performance of Dynamic Contrast-enhanced MR Imaging for Detection of Small Hepatocellular Carcinoma Measuring Up to 2 cm: A Meta-Analysis

(2016) Andrea S. Kierans et al.   RADIOLOGY

CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part II. Extracellular Agents, Hepatobiliary Agents, and Ancillary Imaging Features

(2014) Jin-Young Choi et al.   RADIOLOGY